Karios Technologies is a UCSD-UCLA spinout company that has a novel, patented hydrogel platform that we are using first to prevent postsurgical adhesions with an initial focus on heart transplant patients and children with congenital heart defects.
Timezone: America/Chicago Switch to
9:00am - 10:00am
Appointment confirmation email will be sent upon approval.
We have received your appointment and will send you a confirmation to your provided email upon approval.